1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          South and Central America Systemic Aspergillosis and Systemic Candidasis Market – By Type

1.3.2          South and Central America Systemic Aspergillosis and Systemic Candidasis Market – By Application

1.3.3          South and Central America Systemic Aspergillosis and Systemic Candidasis Market – By Country

2.           Systemic Aspergillosis And Systemic Candidasis Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           South and Central America Systemic Aspergillosis and Systemic Candidasis Market– Market Landscape

4.1          Overview

4.2          PEST Analysis

4.3          Expert Opinions

4.4          Clinical Trials Phases of Products Offered by Companies

4.5          Candida Specific Marketed Products

5.           Systemic Aspergillosis and Systemic Candidasis Market – Key Market Dynamics

5.1          Market Drivers

5.1.1          Rise in Prevalence of Fungal Diseases

5.1.2          Rising Hospital Acquired Fungal Infection

5.2          Market Restraints

5.2.1          Increasing Resistance to Antifungal Drugs

5.2.2          Side Effects of Antifungal Drugs

5.3          Market Opportunities

5.3.1          Increase in R&D Activities and Pipeline of New Drug

5.4          Future Trends

5.4.1          Consolidation of Market

5.5          Impact Analysis

6.           Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Type

6.1          Overview

6.2          South and Central America Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

6.3          Voriconazole

6.3.1          Overview

6.3.2          South and Central America Voriconazole Market Revenue and Forecasts to 2027 (US$ Mn)

6.4          Liposomal Amphotericin B

6.4.1          Overview

6.4.2          South and Central America Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

6.5          Systemic Oral Azoles

6.5.1          Overview

6.5.2          South and Central America Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

6.6          Topical Antifungal Agents

6.6.1          Overview

6.6.2          South and Central America Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

6.7          Others

6.7.1          Overview

6.7.2          South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)

7.           Systemic Aspergillosis and Systemic Candidasis Market Analysis– by Application

7.1          Overview

7.2          South and Central America Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2019 and 2027 (%)

7.3          Chronic Pulmonary Aspergillosis (CPA)

7.3.1          Overview

7.3.2          South and Central America Chronic pulmonary aspergillosis (CPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.4          Allergic Bronchopulmonary Aspergillosis (ABPA)

7.4.1          Overview

7.4.2          South and Central America Allergic bronchopulmonary aspergillosis (ABPA) Market Revenue and Forecasts to 2027 (US$ Mn)

7.5          Gastrointestinal Candidasis

7.5.1          Overview

7.5.2          South and Central America Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.6          Genitourinary Tract Candidasis

7.6.1          Overview

7.6.2          South and Central America Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.7          Others

7.7.1          Overview

7.7.2          South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Systemic Aspergillosis and Systemic Candidasis Market – Regional Analysis

8.1.1          South and Central America: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.2          South and Central America: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.3          South and Central America: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.4          South and Central America: Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

8.1.5          Brazil: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.1             Brazil: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.2             Brazil: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.5.3             Brazil: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.6          Argentina: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1             Argentina: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2             Argentina: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.6.3             Argentina: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

8.1.7          Rest of South and Central America: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027  (USD Million)

8.1.7.1             Rest of South and Central America: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2             Rest of South and Central America: Systemic Aspergillosis and Systemic Candidasis Market, by Type, 2018–2027 (USD Million)

8.1.7.3             Rest of South and Central America: Systemic Aspergillosis and Systemic Candidasis Market, by Application, 2018–2027 (USD Million)

9.           Impact of COVID-19 Pandemic on South and Central America Systemic Aspergillosis and Systemic Candidasis Market

9.1          Impact Assessment of COVID-19 Pandemic

10.        Company Profiles

10.1        Novartis AG

10.1.1        Key Facts

10.1.2        Business Description

10.1.3        Products and Services

10.1.4        Financial Overview

10.1.5        SWOT Analysis

10.1.6        Key Developments

10.2        Sanofi

10.2.1        Key Facts

10.2.2        Business Description

10.2.3        Products and Services

10.2.4        Financial Overview

10.2.5        SWOT Analysis

10.2.6        Key Developments

10.3        Pfizer Inc.

10.3.1        Key Facts

10.3.2        Business Description

10.3.3        Products and Services

10.3.4        Financial Overview

10.3.5        SWOT Analysis

10.3.6        Key Developments

10.4        Merck & Co., Inc.

10.4.1        Key Facts

10.4.2        Business Description

10.4.3        Products and Services

10.4.4        Financial Overview

10.4.5        SWOT Analysis

10.4.6        Key Developments

10.5        Bayer AG

10.5.1        Key Facts

10.5.2        Business Description

10.5.3        Products and Services

10.5.4        Financial Overview

10.5.5        SWOT Analysis

10.5.6        Key Developments

10.7        GlaxoSmithKline plc.

10.7.1        Key Facts

10.7.2        Business Description

10.7.3        Products and Services

10.7.4        Financial Overview

10.7.5        SWOT Analysis

10.7.6        Key Developments

10.8        Abbott

10.8.1        Key Facts

10.8.2        Business Description

10.8.3        Products and Services

10.8.4        Financial Overview

10.8.5        SWOT Analysis

10.8.6        Key Developments

10.9        Cipla Inc.

10.9.1        Key Facts

10.9.2        Business Description

10.9.3        Products and Services

10.9.4        Financial Overview

10.9.5        SWOT Analysis

10.9.6        Key Developments

11.        Appendix

11.1        About the Insight Partners

11.2        Glossary of Terms

LIST OF TABLES

Table 1.              Clinical Trials Phases of Products Offered by Companies

Table 2.              Candida Specific Marketed Products

Table 3.              South and Central America Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 4.              South and Central America Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.              US: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.              Brazil: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027

Table 7.              Argentina: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.              Argentina: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.              Rest of South and Central America: Systemic Aspergillosis and Systemic Candidasis Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10.            Rest of South and Central America: Systemic Aspergillosis and Systemic Candidasis Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.            Glossary of Terms, Systemic Aspergillosis And Systemic Candidasis Market

LIST OF FIGURES

Figure 1.            Systemic Aspergillosis And Systemic Candidasis Market Segmentation

Figure 2.            Systemic Aspergillosis And Systemic Candidasis Market, By Region

Figure 3.            South and Central America Systemic Aspergillosis And Systemic Candidasis Market Overview

Figure 4.            Systemic Oral Azoles Segment Held Largest Share of Type Segment In Systemic Aspergillosis And Systemic Candidasis Market

Figure 5.            Brazil Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.            South and Central America PEST Analysis

Figure 7.            Systemic Aspergillosis and Systemic Candidasis Market Impact Analysis of Drivers and Restraint

Figure 8.            South and Central America Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 9.            South and Central America Voriconazole Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 10.          South and Central America Liposomal Amphotericin B Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.          South and Central America Systemic Oral Azoles Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.          South and Central America Topical Antifungal Agents Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.          South and Central America others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.          South and Central America Systemic Aspergillosis and Systemic Candidasis Market breakdown, by Type, 2019 and 2027 (%)

Figure 15.          South and Central America Chronic pulmonary aspergillosis (CPA) Market Revenue And Forecasts to 2027 (US$ Mn)

Figure 16.          South and Central America Allergic bronchopulmonary aspergillosis (ABPA)Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.          South and Central America Gastrointestinal Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.          South and Central America Genitourinary Tract Candidasis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.          South and Central America others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.          South and Central America: Systemic Aspergillosis and Systemic Candidasis Market Revenue and Forecast to 2027 (USD Million)

Figure 21.          South and Central America: Systemic Aspergillosis and Systemic Candidasis Market, by Country, 2019 & 2027 (%)

Figure 22.          Brazil: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.          Argentina: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.          Rest of South and Central America: Systemic Aspergillosis and Systemic Candidasis Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.          Impact Of COVID-19 Pandemic in South and Central America Market